A cross-circulatory platform for monitoring innate allo-responses in lung grafts.
Lung transplantation is the only curative option for end-stage chronic respiratory diseases. However the survival rate is only about 50% at 5 years. Although experimental evidences have shown that innate allo-responses impact on the clinical outcome, the knowledge of the involved mechanisms involved...
保存先:
| 主要な著者: | , , , , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Public Library of Science (PLoS)
2023-01-01
|
| シリーズ: | PLoS ONE |
| オンライン・アクセス: | https://doi.org/10.1371/journal.pone.0285724 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
